CAROL WALKER: Open Payments
NPI 1396769428 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 36 payments from 21 companies in 2025. Trend: 2023 $683 · 2024 $735 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Lilly USA, LLC | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
| Lundbeck LLC | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Amgen Inc. | 2 | $33 |
Products named: REXULTI, Dexcom G6 Transmitter, CAPLYTA, FARXIGA, MOUNJARO, TZIELD, SHINGRIX, General - Pain Management.
Industry payments across GA — which companies pay providers there.
